Epistasis among Deleterious Mutations in the HIV-1 Protease

Journal of Molecular Biology

Volumn 392, Issue 2, 2009, Pages 243-250

  Parera, Mariona ^a   Perez Alvarez, Nuria ^b,c   Clotet, Bonaventura ^a,b   Martínez, Miguel Angel ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

Author keywords

epistasis; fitness; HIV 1; mutation; protease

Indexed keywords

NUCLEOTIDE; PROTEINASE;

ARTICLE; BACTERIOPHAGE LAMBDA; BACTERIUM; CONTROLLED STUDY; ENZYME ACTIVITY; EPISTASIS; EUKARYOTE; GENE INTERACTION; GENE MUTATION; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; LETHALITY; MOLECULAR EVOLUTION; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRUS;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 68949209095     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.07.015     Document Type: Article

References (66)

1. Pal C., Papp B., and Lercher M.J. An integrated view of protein evolution. Nat. Rev., Genet. 7 (2006) 337-348
2. DePristo M.A., Weinreich D.M., and Hartl D.L. Missense meanderings in sequence space: a biophysical view of protein evolution. Nat. Rev., Genet. 6 (2005) 678-687
3. Kouyos R.D., Silander O.K., and Bonhoeffer S. Epistasis between deleterious mutations and the evolution of recombination. Trends Ecol. Evol. 22 (2007) 308-315
4. Bershtein S., Segal M., Bekerman R., Tokuriki N., and Tawfik D.S. Robustness-epistasis link shapes the fitness landscape of a randomly drifting protein. Nature 444 (2006) 929-932
5. Bridgham J.T., Carroll S.M., and Thornton J.W. Evolution of hormone-receptor complexity by molecular exploitation. Science 312 (2006) 97-101
6. Ortlund E.A., Bridgham J.T., Redinbo M.R., and Thornton J.W. Crystal structure of an ancient protein: evolution by conformational epistasis. Science 317 (2007) 1544-1548
7. Tomatis P.E., Fabiane S.M., Simona F., Carloni P., Sutton B.J., and Vila A.J. Adaptive protein evolution grants organismal fitness by improving catalysis and flexibility. Proc. Natl Acad. Sci. USA 105 (2008) 20605-20610
8. Lenski R.E., Barrick J.E., and Ofria C. Balancing robustness and evolvability. PLoS Biol. 4 (2006) e428
9. Camps M., Herman A., Loh E., and Loeb L.A. Genetic constraints on protein evolution. Crit. Rev. Biochem. Mol. Biol. 42 (2007) 313-326
10. Weinreich D.M., Delaney N.F., DePristo M.A., and Hartl D.L. Darwinian evolution scan follow only very few mutational paths to fitter proteins. Science 312 (2006) 111-114
11. Dean A.M., and Thornton J.W. Mechanistic approaches to the study of evolution: the functional synthesis. Nat. Rev., Genet. 8 (2007) 675-688
12. Gulick R.M., Mellors J.W., Havlir D., Eron J.J., Gonzalez C., McMahon D., et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337 (1997) 734-739
13. Hammer S.M., Squires K.E., Hughes M.D., Grimes J.M., Demeter L.M., Currier J.S., et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N. Engl. J. Med. 337 (1997) 725-733
14. Parera M., Fernandez G., Clotet B., and Martinez M.A. HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions. Mol. Biol. Evol. 24 (2007) 382-387
15. Sices H.J., and Kristie T.M. A genetic screen for the isolation and characterization of site-specific proteases. Proc. Natl. Acad. Sci. USA 95 (1998) 2828-2833
16. Martinez M.A., Cabana M., Parera M., Gutierrez A., Este J.A., and Clotet B. A bacteriophage lambda-based genetic screen for characterization of the activity and phenotype of the human immunodeficiency virus type 1 protease. Antimicrob. Agents Chemother. 44 (2000) 1132-1139
17. Cabana M., Fernandez G., Parera M., Clotet B., and Martinez M.A. Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions. Virology 300 (2002) 71-78
18. Fernandez G., Clotet B., and Martinez M.A. Fitness landscape of human immunodeficiency virus type 1 protease quasispecies. J. Virol. 81 (2007) 2485-2496
19. Tokuriki N., and Tawfik D.S. Protein dynamism and evolvability. Science 324 (2009) 203-207
20. Loeb D.D., Swanstrom R., Everitt L., Manchester M., Stamper S.E., and Hutchison III C.A. Complete mutagenesis of the HIV-1 protease. Nature 340 (1989) 397-400
21. Guo H.H., Choe J., and Loeb L.A. Protein tolerance to random amino acid change. Proc. Natl Acad. Sci. USA 101 (2004) 9205-9210
22. Loh E., Choe J., and Loeb L.A. Highly tolerated amino acid substitutions increase the fidelity of Escherichia coli DNA polymerase I. J. Biol. Chem. 282 (2007) 12201-12209
23. Markiewicz P., Kleina L.G., Cruz C., Ehret S., and Miller J.H. Genetic studies of the lac repressor. XIV. Analysis of 4000 altered Escherichia coli lac repressors reveals essential and non-essential residues, as well as "spacers" which do not require a specific sequence. J. Mol. Biol. 240 (1994) 421-433
24. Axe D.D., Foster N.W., and Fersht A.R. A search for single substitutions that eliminate enzymatic function in a bacterial ribonuclease. Biochemistry 37 (1998) 7157-7166
25. Rennell D., Bouvier S.E., Hardy L.W., and Poteete A.R. Systematic mutation of bacteriophage T4 lysozyme. J. Mol. Biol. 222 (1991) 67-88
26. Martinez-Picado J., Savara A.V., Sutton L., and D'Aquila R.T. Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1. J. Virol. 73 (1999) 3744-3752
27. Nijhuis M., Schuurman R., de Jong D., Erickson J., Gustchina E., Albert J., et al. Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS 13 (1999) 2349-2359
28. Wilke C.O., and Adami C. Evolution of mutational robustness. Mutat. Res. 522 (2003) 3-11
29. Elena S.F., Carrasco P., Daros J.A., and Sanjuan R. Mechanisms of genetic robustness in RNA viruses. EMBO Rep. 7 (2006) 168-173
30. Wei X., Ghosh S.K., Taylor M.E., Johnson V.A., Emini E.A., Deutsch P., et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373 (1995) 117-122
31. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., and Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373 (1995) 123-126
32. Taverna D.M., and Goldstein R.A. Why are proteins so robust to site mutations?. J. Mol. Biol. 315 (2002) 479-484
33. Wagner A. Robustness, evolvability, and neutrality. FEBS Lett. 579 (2005) 1772-1778
34. Aharoni A., Gaidukov L., Khersonsky O., Gould S.M., Roodveldt C., and Tawfik D.S. The 'evolvability' of promiscuous protein functions. Nat. Genet. 37 (2005) 73-76
35. Bloom J.D., Labthavikul S.T., Otey C.R., and Arnold F.H. Protein stability promotes evolvability. Proc. Natl Acad. Sci. USA 103 (2006) 5869-5874
36. Mansky L.M., and Temin H.M. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69 (1995) 5087-5094
37. Jung A., Maier R., Vartanian J.P., Bocharov G., Jung V., Fischer U., et al. Multiply infected spleen cells in HIV patients. Nature 418 (2002) 144
38. Rhodes T., Wargo H., and Hu W.S. High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J. Virol. 77 (2003) 11193-11200
39. Levy D.N., Aldrovandi G.M., Kutsch O., and Shaw G.M. Dynamics of HIV-1 recombination in its natural target cells. Proc. Natl Acad. Sci. USA 101 (2004) 4204-4209
40. Coffin J.M. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267 (1995) 483-489
41. de Visser J.A., and Elena S.F. The evolution of sex: empirical insights into the roles of epistasis and drift. Nat. Rev., Genet. 8 (2007) 139-149
42. Bonhoeffer S., Chappey C., Parkin N.T., Whitcomb J.M., and Petropoulos C.J. Evidence for positive epistasis in HIV-1. Science 306 (2004) 1547-1550
43. Burch C.L., and Chao L. Epistasis and its relationship to canalization in the RNA virus phi 6. Genetics 167 (2004) 559-567
44. Sanjuan R., Moya A., and Elena S.F. The contribution of epistasis to the architecture of fitness in an RNA virus. Proc. Natl Acad. Sci. USA 101 (2004) 15376-15379
45. van Opijnen T., Boerlijst M.C., and Berkhout B. Effects of random mutations in the human immunodeficiency virus type 1 transcriptional promoter on viral fitness in different host cell environments. J. Virol. 80 (2006) 6678-6685
46. Pepin K.M., and Wichman H.A. Variable epistatic effects between mutations at host recognition sites in phiX174 bacteriophage. Evolution 61 (2007) 1710-1724
47. Elena S.F., and Lenski R.E. Test of synergistic interactions among deleterious mutations in bacteria. Nature 390 (1997) 395-398
48. de Visser J.A., Hoekstra R.F., and van den Ende H. An experimental test for synergistic epistasis and its application in Chlamydomonas. Genetics 145 (1997) 815-819
49. Whitlock M.C., and Bourguet D. Factors affecting the genetic load in Drosophila: synergistic epistasis and correlations among fitness components. Evolution 54 (2000) 1654-1660
50. Wloch D.M., Szafraniec K., Borts R.H., and Korona R. Direct estimate of the mutation rate and the distribution of fitness effects in the yeast Saccharomyces cerevisiae. Genetics 159 (2001) 441-452
51. Shaw F.H., Geyer C.J., and Shaw R.G. A comprehensive model of mutations affecting fitness and inferences for Arabidopsis thaliana. Evolution 56 (2002) 453-463
52. You L., and Yin J. Dependence of epistasis on environment and mutation severity as revealed by in silico mutagenesis of phage t7. Genetics 160 (2002) 1273-1281
53. Lenski R.E., Ofria C., Pennock R.T., and Adami C. The evolutionary origin of complex features. Nature 423 (2003) 139-144
54. Wilke C.O., Lenski R.E., and Adami C. Compensatory mutations cause excess of antagonistic epistasis in RNA secondary structure folding. BMC Evol. Biol. 3 (2003) 3
55. Maisnier-Patin S., Roth J.R., Fredriksson A., Nystrom T., Berg O.G., and Andersson D.I. Genomic buffering mitigates the effects of deleterious mutations in bacteria. Nat. Genet. 37 (2005) 1376-1379
56. Poon A., and Chao L. The rate of compensatory mutation in the DNA bacteriophage phiX174. Genetics 170 (2005) 989-999
57. Sanjuan R., and Elena S.F. Epistasis correlates to genomic complexity. Proc. Natl Acad. Sci. USA 103 (2006) 14402-14405
58. Sanjuan R., Forment J., and Elena S.F. In silico predicted robustness of viroids RNA secondary structures. I. The effect of single mutations. Mol. Biol. Evol. 23 (2006) 1427-1436
59. Azevedo R.B., Lohaus R., Srinivasan S., Dang K.K., and Burch C.L. Sexual reproduction selects for robustness and negative epistasis in artificial gene networks. Nature 440 (2006) 87-90
60. Jasnos L., and Korona R. Epistatic buffering of fitness loss in yeast double deletion strains. Nat. Genet. 39 (2007) 550-554
61. Beerenwinkel N., Pachter L., Sturmfels B., Elena S.F., and Lenski R.E. Analysis of epistatic interactions and fitness landscapes using a new geometric approach. BMC Evol. Biol. 7 (2007) 60
62. MacCarthy T., and Bergman A. Coevolution of robustness, epistasis, and recombination favors asexual reproduction. Proc. Natl Acad. Sci. USA 104 (2007) 12801-12806
63. Sambrook J., and Russell D.W. Molecular Cloning: A Laboratory Manual (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
64. Martinez M.A., and Clotet B. Genetic screen for monitoring hepatitis C virus NS3 serine protease activity. Antimicrob. Agents Chemother. 47 (2003) 1760-1765
65. Parera M., Clotet B., and Martinez M.A. Genetic screen for monitoring severe acute respiratory syndrome coronavirus 3C-like protease. J. Virol. 78 (2004) 14057-14061
66. Casella G., and Berger R.L. Statistical Inference. 2nd Edition (2002), Duxbury Resource Center